Lupin Limited

BSE : 500257 | NSE : LUPIN
Industry : Pharma Drugs | ISIN : INE326A01037 | FreeFloat : 52.85% | FnO : Yes | LotSize : 850
Intellectual Capital (IC)-7,189.38
Net Worth (NW)12,264.40
Intrinsic Worth (IW)5,075.02
Market Cap (MC)33,365.79
Economic Value Added-247.95
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)-141.66%
IC Gross Margin (EBITDA/IC)-19.48%
IC Net Margin (NPT/IC)1.97%
Knowledge Turnover (Sales/IC)-2.24
Market to Intrinsic Value (MC/IW)6.57
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 111.60Rs. 733.70
20 Mar 2023 ---- Rs. 646.40
-10.60     -1.64%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 657.92SellStrong Sell
KB > 50% : No50 DMA : Rs. 706.79
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
3845.74
4054.34
818.00
603.74
496.36
391.29
-148.95
Jun-20
C
3527.86
3571.14
531.92
317.28
273.02
106.90
183.54
Sep-20
C
3835.00
3859.96
606.56
393.83
360.21
211.02
239.61
Dec-20
C
4017.36
4038.53
800.08
555.76
524.84
438.25
646.59
Mar-21
C
3783.10
3841.32
765.94
550.22
518.38
460.36
410.76
Jun-21
C
4270.19
4298.02
992.72
783.96
750.49
542.46
628.65
Sep-21
C
4091.33
4164.14
-1251.02
-2170.35
-2204.78
-2098.04
-2213.45
Dec-21
C
4160.93
4194.99
403.91
200.48
167.08
545.52
513.43
Mar-22
C
3883.03
3898.71
283.66
-43.53
-85.00
-517.98
-357.31
Jun-22
C
3743.84
3749.40
237.88
45.05
2.27
-89.08
-187.26
Sep-22
C
4091.16
4145.52
467.93
264.46
209.58
129.73
51.52
Dec-22
C
4244.56
4322.22
550.63
330.23
246.14
157.65
340.71
* C - Consolidated, S - Standalone